Food Effect and Bioavailability of Deflazacort Formulations in Healthy Volunteers
Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
This is a Phase 1, single-center, single-dose, randomized, 5-period crossover study designed
to assess the comparative bioavailability and food effect of deflazacort. A total of 45
subjects will be randomly assigned to receive 1 of 5 treatment sequences. Each dosing
sequence will be enrolled in parallel and all subjects will receive all 5 treatments in a
crossover fashion.
Phase:
Phase 1
Details
Lead Sponsor:
Marathon Pharmaceuticals, LLC PTC Therapeutics
Collaborators:
ICON Development Solutions ICON Development Solutions, LLC